News on Sodium Oxybate Therapy

 In the Annals of the Rheumatic Diseases June 2012 volume 71 issue 6, we found this article about the results of an international phase 3 trial on a sodium oxybate therapy.

The conclusion of this trial is as follows: “These results, combined with findings from previous phase 2 and 3 studies, provide supportive evidence that SXB therapy affords important benefits across multiple symptoms in subjects with fibromyalgia”

The research was conducted by Michael Spaeth, Robert M. Bennet, Beverly A Benson, Y Grace Wang, Chinglin Lai, and Ernst H. Choy.

For the full article click here.

Facebook

Stay updated on facebook and become a fan of our page. You will updated from time to time about our activities.

Donate

You can do this by making a donation with PayPal. To do this just click on the "donate" button and follow the instructions.

Contact

E-mail : contact@enfa-europe.eu